Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis[RNA-seq]

ABSTRACT: Stellate cells are in utero markers of pancreatic disease in cystic fibrosis[RNA-seq]

PROVIDER: PRJNA1070273 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27755472_1.fastq.gz	Fastqsanger.gz
	SRR27755472_2.fastq.gz	Fastqsanger.gz
	SRR27755473_1.fastq.gz	Fastqsanger.gz
	SRR27755473_2.fastq.gz	Fastqsanger.gz
	SRR27755474_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis

Project description:Stellate cells are in utero markers of pancreatic disease in cystic fibrosis

| PRJNA1070269 | ENA

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis [scRNA-seq]

Project description:Stellate cells are in utero markers of pancreatic disease in cystic fibrosis [scRNA-seq]

| PRJNA1070271 | ENA

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis[RNA-seq]

Project description:Pancreatic fibrosis is an early diagnostic feature of the common inherited disorder cystic fibrosis (CF). Many people with CF (pwCF) are pancreatic insufficient from birth and the replacement of acinar tissue with cystic lesions and fibrosis is a progressive phenotype that may later lead to diabetes. Little is known about the initiating events in the fibrotic process though it may be a sequela of inflammation in the pancreatic ducts resulting from loss of CFTR impairing normal fluid secretion. Here we use the sheep model of CF (CFTR-/-) to examine the evolution of pancreatic disease through gestation. Transcriptomic evidence from bulk RNA-seq showed alterations in the CF pancreas by 65 days of gestation, which are accompanied by marked pathological changes by 80 days gestation. These include a profound fibrotic response, confirmed by immunostaining for COL1A1, SMA and SPARC, together with acinar destruction. Moreover, using scRNA-seq we identify a unique cell population that is significantly overrepresented in the CF animals at 80- and 120-days gestation, as are activated stellate cells at term. This cellular imbalance likely has a pivotal role in the evolution of CF pancreatic disease and may provide therapeutic opportunities to delay or prevent CF pancreatic destruction.

2025-03-17 | GSE254375 | GEO

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis [scRNA-seq]

Project description:Pancreatic fibrosis is an early diagnostic feature of the common inherited disorder cystic fibrosis (CF). Many people with CF (pwCF) are pancreatic insufficient from birth and the replacement of acinar tissue with cystic lesions and fibrosis is a progressive phenotype that may later lead to diabetes. Little is known about the initiating events in the fibrotic process though it may be a sequela of inflammation in the pancreatic ducts resulting from loss of CFTR impairing normal fluid secretion. Here we use the sheep model of CF (CFTR-/-) to examine the evolution of pancreatic disease through gestation. Transcriptomic evidence from bulk RNA-seq showed alterations in the CF pancreas by 65 days of gestation, which are accompanied by marked pathological changes by 80 days gestation. These include a profound fibrotic response, confirmed by immunostaining for COL1A1, αSMA and SPARC, together with acinar destruction. Moreover, using scRNA-seq we identify a unique cell population that is significantly overrepresented in the CF animals at 80- and 120-days gestation, as are activated stellate cells at term. This cellular imbalance likely has a pivotal role in the evolution of CF pancreatic disease and may provide therapeutic opportunities to delay or prevent CF pancreatic destruction.

2025-03-17 | GSE254374 | GEO

Colorectal Cancer Screening in Cystic Fibrosis

Project description:This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).

| 2726863 | ecrin-mdr-crc

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis.

Project description:BackgroundPancreatic fibrosis is an early diagnostic feature of the common inherited disorder cystic fibrosis (CF). Many people with CF (pwCF) are pancreatic insufficient from birth and the replacement of acinar tissue with cystic lesions and fibrosis is a progressive phenotype that may later lead to diabetes. Little is known about the initiating events in the fibrotic process though it may be a sequela of inflammation in the pancreatic ducts resulting from loss of CFTR impairing normal fluid secretion. Here we use a sheep model of CF (CFTR-/-) to examine the evolution of pancreatic disease through gestation.MethodsFetal pancreas was collected at six time points from 50-days of gestation through to term, which is equivalent to ~ 13 weeks to term in human. RNA was extracted from tissue for bulk RNA-seq and single cells were prepared from 80-day, 120-day and term samples for scRNA-seq. Data were validated by immunochemistry.ResultsTranscriptomic evidence from bulk RNA-seq showed alterations in the CFTR-/- pancreas by 65-days of gestation, which are accompanied by marked pathological changes by 80-days of gestation. These include a fibrotic response, confirmed by immunostaining for COL1A1, αSMA and SPARC, together with acinar loss. Moreover, using scRNA-seq we identify a unique cell population that is significantly overrepresented in the CFTR-/- animals at 80- and 120-days gestation, as are stellate cells at term.ConclusionThe transcriptomic changes and cellular imbalance that we observe likely have pivotal roles in the evolution of CF pancreatic disease and may provide therapeutic opportunities to delay or prevent pancreatic destruction in CF.

| S-EPMC11304907 | biostudies-literature

Stellate cells are in utero markers of pancreatic disease in cystic fibrosis

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-03-17 | GSE254376 | GEO

Cystic Fibrosis Keystone Species

Project description:Cystic Fibrosis Keystone Species

| PRJNA587705 | ENA

Transcriptome profile of Primary Human Lung Fibroblasts (Cystic Fibrosis vs. Non-Cystic Fibrosis) [2D]

Project description:The transcriptomic profile of cystic fibrosis human lung fibroblasts was compared to normal human lung fibroblasts.

2020-06-15 | GSE141535 | GEO

Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress

Project description:CF's physiopathology is poorly explained by the mutation alone. The oxydative stress could be a major factor of this illness . Study its impact on transcriptome's CF cell line could be ameliorate our understanding of the evolution of cystic fibrosis. we used microarray technology to evaluate under oxydative stress, the transcriptional state of an epithelial lung cell issued from a human with cystic fibrosis and to identify a set of modulated genes associated to survival cell processes. the two cell lines are cultivated to Air-liquid Interface for RNA extraction and hybridization on Affymetrix microarrays. Each condition is triplicated. For the oxidative stress conditions, the two cell lines are treated on apical site by 15 µl of DMNQ (2,3-dimethoxy-1,4-naphtoquinone) ,concentrated at 15 µM, during 24 hours before RNA extraction.

2012-08-02 | E-GEOD-39843 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data